Oncolytics Biotech Inc T.ONC

Merck's Keytruda and ONCY's pelareorep in pancreatic cancer

[Noteable]

This 2020 study results are outlined in the following link.

https://pubmed.ncbi.nlm.nih.gov/31694832/

[Noteable]

Pembrolizumab in Combination with the Oncolytic Virus Pelareorep and Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma: A Phase Ib Study

[ukrop13]

This post has been removed in accordance with Community Policy

[Noteable]

March 14, 2023 - "We were particularly excited to see a partial response deepen into a confirmed complete response as of the latest data cut, since this further indicates potentially durable anti-cancer effects from the combination therapy," said Thomas C. Heineman, M.D., Ph.D., Chief Medical Officer of Oncolytics Biotech. https://www.prnewswire.com/news-releases/rise-in-biotech

[Noteable]

"Drugs with Fast Track designation may also qualify for accelerated approval and priority review if relevant criteria are met."

[fox7mf]

That was an interesting,  yet short lived $0.26 AH spike today...PFE dumping more $$$;) joking.

[Noteable]

From the most recent coverage on ONCY and what has been fully discussed on this message board - "Drugs with Fast Track designation may also qualify for accelerated approval and priority review if relevant criteria are met."